Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis.

grass pollen house dust mite rhinitis tobacco

Journal

Postepy dermatologii i alergologii
ISSN: 1642-395X
Titre abrégé: Postepy Dermatol Alergol
Pays: Poland
ID NLM: 101168357

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 05 03 2018
accepted: 11 07 2018
entrez: 31 1 2020
pubmed: 31 1 2020
medline: 31 1 2020
Statut: ppublish

Résumé

Allergen specific immunotherapy (AIT) is the only treatment modifying the course of the disease in patients allergic to airborne allergens. It has been proven to be effective in allergic populations, however individual patients vary in terms of response to the therapy. To assess the factors that might affect the efficacy of AIT. Patients treated with AIT for grass pollen or house dust mites were included. The efficacy of AIT was assessed with the use of Allergy Control Score (ACS), performed before and at least 1 year after AIT. The following variables were assessed as potential risk factors for a worse response to AIT: age, gender, type of allergy, type of allergen, type of vaccine, type of AIT and smoking history. The study group consisted of 145 subjects.AIT was effective in the entire group; the mean ACS results decreased from 21.14 to 14.41 points ( Smoking history may affect AIT outcomes.

Identifiants

pubmed: 31997993
doi: 10.5114/ada.2018.80654
pii: 80654
pmc: PMC6986293
doi:

Types de publication

Journal Article

Langues

eng

Pagination

673-676

Informations de copyright

Copyright © 2019 Termedia.

Références

Acta Odontol Scand. 2017 Mar;75(2):94-99
pubmed: 27899029
Allergy. 2001 Apr;56(4):328-32
pubmed: 11284801
Br Med J (Clin Res Ed). 1981 Nov 7;283(6301):1215-7
pubmed: 6797514
J Allergy Clin Immunol. 2015 Sep;136(3):556-68
pubmed: 26162571
Curr Allergy Asthma Rep. 2007 Jul;7(4):303-9
pubmed: 17547853
Allergol Immunopathol (Madr). 2011 Mar-Apr;39(2):60-7
pubmed: 21216083
Eur J Public Health. 2007 Jun;17(3):278-84
pubmed: 17060335
Adv Clin Exp Med. 2013 Nov-Dec;22(6):809-15
pubmed: 24431309
Allergol Immunopathol (Madr). 2013 May-Jun;41(3):194-200
pubmed: 22405467
J Laryngol Otol. 2005 Dec;119(12):955-7
pubmed: 16354357
Ann Allergy Asthma Immunol. 2009 Sep;103(3):195-200
pubmed: 19788015
J Hypertens. 2005 Jun;23(6):1261-6
pubmed: 15894903
Pediatr Int. 2013 Dec;55(6):680-4
pubmed: 23809249
Rhinology. 2015 Dec;53(4):325-31
pubmed: 26362673
J Allergy Clin Immunol. 2015 Dec;136(6):1511-1516
pubmed: 26371838
J Allergy Clin Immunol. 2008 Jan;121(1):227-32
pubmed: 18206509
Int Forum Allergy Rhinol. 2015 Jun;5(6):471-6
pubmed: 25884913
Allergy. 2011 May;66(5):629-36
pubmed: 21261656
Ann Allergy Asthma Immunol. 2014 Dec;113(6):587-92
pubmed: 25454016
Allergy. 2013 Mar;68(3):347-54
pubmed: 23346908

Auteurs

Jan Romantowski (J)

Department of Allergology, Medical University of Gdansk, Gdansk, Poland.

Krzysztof Specjalski (K)

Department of Allergology, Medical University of Gdansk, Gdansk, Poland.

Łata Jakub (Ł)

Department of Allergology, Medical University of Gdansk, Gdansk, Poland.

Eliza Wasilewska (E)

Department of Allergology, Medical University of Gdansk, Gdansk, Poland.

Marta Chełmińska (M)

Department of Allergology, Medical University of Gdansk, Gdansk, Poland.

Ewa Jassem (E)

Department of Allergology, Medical University of Gdansk, Gdansk, Poland.

Marek Niedoszytko (M)

Department of Allergology, Medical University of Gdansk, Gdansk, Poland.

Classifications MeSH